- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03759990
Tracheal Intubation in Morbidly Obese (BMI>35) and in Lean (BMI<30) Patients Using McGrath MAC X-Blade
March 3, 2020 updated by: Zehra Ipek ARSLAN, Kocaeli University
A Comparison of Morbidly Obese and Lean
80 lean (BMI<35) and morbidly obese (BMI>35) patients undergoing elective surgery were enrolled in this prospective ransomİzed study were intubated using McGrath MAC X-Blade.
The demographic and airway variables of patients and insertion and intubation times with these dievices, need for optimisation maneuvers, hemodynamic changes and minör postoperative complications were recorded.
Study Overview
Detailed Description
80 lean (BMI<35) and morbidly obese (BMI>35) patients undergoing elective surgery were enrolled in this prospective ransomİzed study were intubated using McGrath MAC X-Blade.
The demographic and airway variables of patients were recorded.
Airway management variables Cormack-Lehan grades, insertion and intubation times, need for optimization maneuvers ( cricoid pressure, re-inserting, drawback) , hemodynamic changes in heart rate , blood pressure and minor postoperative complications such as sore throat, dysphasia, hoarseness were recorded.
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kocaeli, Turkey
- Kocaeli University Medical Faculty
-
Kocaeli, Turkey, 41900
- Kocaeli University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria: > 18 age <65 age
bmı 35
- undergoing elective surgery requiring endotracheal intubation
Exclusion Criteria: -pregnant
- <18 and >65 years of age
- bmı<35
- upper respiratory tract infection past ten days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: insertion time
|
Videolaryngoscope used in intubation
Videolaryngoscope used in intubation
|
Active Comparator: intubation time
|
Videolaryngoscope used in intubation
Videolaryngoscope used in intubation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
intubation time
Time Frame: 2 months
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2018
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
December 1, 2018
Study Registration Dates
First Submitted
November 29, 2018
First Submitted That Met QC Criteria
November 29, 2018
First Posted (Actual)
November 30, 2018
Study Record Updates
Last Update Posted (Actual)
March 4, 2020
Last Update Submitted That Met QC Criteria
March 3, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KOU-KAEK 2018 - 202
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity, Morbid
-
ClinTrio Ltd.UnknownMorbid Obesity Requiring Bariatric SurgeryBelgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
-
Centre Hospitalier Universitaire de NiceCompletedMorbid Obesity D009765France
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Endolumik, IncWest Virginia UniversityNot yet recruitingMorbid ObesityUnited States
-
Rijnstate HospitalRecruiting
-
Laval UniversityCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...Recruiting
-
University of WashingtonUnited States Department of DefenseWithdrawn
-
Helsinki University Central HospitalActive, not recruiting
-
IHU StrasbourgWithdrawnMorbid Obesity
Clinical Trials on lean
-
University of BergenBergen Medical Research Foundation; Skretting ASA; Leroy Seafood Group ASACompletedObesity | Metabolic DisordersNorway
-
University of Illinois at Urbana-ChampaignRecruiting
-
Yale UniversityCompletedObesity | Breast Cancer SurvivorshipUnited States
-
George Mason UniversityRecruiting
-
University of JazanCompletedLow Back Pain, MechanicalSaudi Arabia
-
University of BergenBergen Medical Research Foundation; Skretting ASA; Leroy Seafood Group ASACompletedObesity | OverweightNorway
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH)Completed
-
Boston Children's HospitalAcademy of Nutrition and DieteticsRecruitingCongenital Heart Disease | ICU Acquired Weakness | Catabolic StateUnited States
-
Catholic University of the Sacred HeartWithdrawn